Global Anticoagulants Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 17 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

According to our (Global Info Research) latest study, the global Anticoagulants Drug market size was valued at USD 30180 million in 2022 and is forecast to a readjusted size of USD 37520 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Americas is the largest Anticoagulant Drugs market with about 51% market share. Europe is follower, accounting for about 27% market share.The key manufacturers are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo etc. Top 3 companies occupied about 56% market share.

This report is a detailed and comprehensive analysis for global Anticoagulants Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Anticoagulants Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Anticoagulants Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Anticoagulants Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Anticoagulants Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anticoagulants Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anticoagulants Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US) and Daiichi Sankyo (Japan), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Anticoagulants Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Novel Oral Anticoagulants (NOACs)
    Warfarin (VKA)
    Others

Market segment by Application
    Hospital
    Clinic
    Others

Major players covered
    C. H. Boehringer Sohn (Germany)
    Bristol-Myers Squibb (US)
    Johnson & Johnson (US)
    Pfizer (US)
    Daiichi Sankyo (Japan)
    Portola Pharmaceuticals (US)
    Roche (Switzerland)
    Abbott (US)
    Siemens (Germany)
    Alere (US)
    CoaguSense (US)

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticoagulants Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anticoagulants Drug, with price, sales, revenue and global market share of Anticoagulants Drug from 2018 to 2023.
Chapter 3, the Anticoagulants Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticoagulants Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anticoagulants Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anticoagulants Drug.
Chapter 14 and 15, to describe Anticoagulants Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Anticoagulants Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Anticoagulants Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Novel Oral Anticoagulants (NOACs)
        1.3.3 Warfarin (VKA)
        1.3.4 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Anticoagulants Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Others
    1.5 Global Anticoagulants Drug Market Size & Forecast
        1.5.1 Global Anticoagulants Drug Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Anticoagulants Drug Sales Quantity (2018-2029)
        1.5.3 Global Anticoagulants Drug Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 C. H. Boehringer Sohn (Germany)
        2.1.1 C. H. Boehringer Sohn (Germany) Details
        2.1.2 C. H. Boehringer Sohn (Germany) Major Business
        2.1.3 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product and Services
        2.1.4 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 C. H. Boehringer Sohn (Germany) Recent Developments/Updates
    2.2 Bristol-Myers Squibb (US)
        2.2.1 Bristol-Myers Squibb (US) Details
        2.2.2 Bristol-Myers Squibb (US) Major Business
        2.2.3 Bristol-Myers Squibb (US) Anticoagulants Drug Product and Services
        2.2.4 Bristol-Myers Squibb (US) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Bristol-Myers Squibb (US) Recent Developments/Updates
    2.3 Johnson & Johnson (US)
        2.3.1 Johnson & Johnson (US) Details
        2.3.2 Johnson & Johnson (US) Major Business
        2.3.3 Johnson & Johnson (US) Anticoagulants Drug Product and Services
        2.3.4 Johnson & Johnson (US) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Johnson & Johnson (US) Recent Developments/Updates
    2.4 Pfizer (US)
        2.4.1 Pfizer (US) Details
        2.4.2 Pfizer (US) Major Business
        2.4.3 Pfizer (US) Anticoagulants Drug Product and Services
        2.4.4 Pfizer (US) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Pfizer (US) Recent Developments/Updates
    2.5 Daiichi Sankyo (Japan)
        2.5.1 Daiichi Sankyo (Japan) Details
        2.5.2 Daiichi Sankyo (Japan) Major Business
        2.5.3 Daiichi Sankyo (Japan) Anticoagulants Drug Product and Services
        2.5.4 Daiichi Sankyo (Japan) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Daiichi Sankyo (Japan) Recent Developments/Updates
    2.6 Portola Pharmaceuticals (US)
        2.6.1 Portola Pharmaceuticals (US) Details
        2.6.2 Portola Pharmaceuticals (US) Major Business
        2.6.3 Portola Pharmaceuticals (US) Anticoagulants Drug Product and Services
        2.6.4 Portola Pharmaceuticals (US) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Portola Pharmaceuticals (US) Recent Developments/Updates
    2.7 Roche (Switzerland)
        2.7.1 Roche (Switzerland) Details
        2.7.2 Roche (Switzerland) Major Business
        2.7.3 Roche (Switzerland) Anticoagulants Drug Product and Services
        2.7.4 Roche (Switzerland) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Roche (Switzerland) Recent Developments/Updates
    2.8 Abbott (US)
        2.8.1 Abbott (US) Details
        2.8.2 Abbott (US) Major Business
        2.8.3 Abbott (US) Anticoagulants Drug Product and Services
        2.8.4 Abbott (US) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Abbott (US) Recent Developments/Updates
    2.9 Siemens (Germany)
        2.9.1 Siemens (Germany) Details
        2.9.2 Siemens (Germany) Major Business
        2.9.3 Siemens (Germany) Anticoagulants Drug Product and Services
        2.9.4 Siemens (Germany) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Siemens (Germany) Recent Developments/Updates
    2.10 Alere (US)
        2.10.1 Alere (US) Details
        2.10.2 Alere (US) Major Business
        2.10.3 Alere (US) Anticoagulants Drug Product and Services
        2.10.4 Alere (US) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Alere (US) Recent Developments/Updates
    2.11 CoaguSense (US)
        2.11.1 CoaguSense (US) Details
        2.11.2 CoaguSense (US) Major Business
        2.11.3 CoaguSense (US) Anticoagulants Drug Product and Services
        2.11.4 CoaguSense (US) Anticoagulants Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 CoaguSense (US) Recent Developments/Updates

3 Competitive Environment: Anticoagulants Drug by Manufacturer
    3.1 Global Anticoagulants Drug Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Anticoagulants Drug Revenue by Manufacturer (2018-2023)
    3.3 Global Anticoagulants Drug Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Anticoagulants Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Anticoagulants Drug Manufacturer Market Share in 2022
        3.4.2 Top 6 Anticoagulants Drug Manufacturer Market Share in 2022
    3.5 Anticoagulants Drug Market: Overall Company Footprint Analysis
        3.5.1 Anticoagulants Drug Market: Region Footprint
        3.5.2 Anticoagulants Drug Market: Company Product Type Footprint
        3.5.3 Anticoagulants Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Anticoagulants Drug Market Size by Region
        4.1.1 Global Anticoagulants Drug Sales Quantity by Region (2018-2029)
        4.1.2 Global Anticoagulants Drug Consumption Value by Region (2018-2029)
        4.1.3 Global Anticoagulants Drug Average Price by Region (2018-2029)
    4.2 North America Anticoagulants Drug Consumption Value (2018-2029)
    4.3 Europe Anticoagulants Drug Consumption Value (2018-2029)
    4.4 Asia-Pacific Anticoagulants Drug Consumption Value (2018-2029)
    4.5 South America Anticoagulants Drug Consumption Value (2018-2029)
    4.6 Middle East and Africa Anticoagulants Drug Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Anticoagulants Drug Sales Quantity by Type (2018-2029)
    5.2 Global Anticoagulants Drug Consumption Value by Type (2018-2029)
    5.3 Global Anticoagulants Drug Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Anticoagulants Drug Sales Quantity by Application (2018-2029)
    6.2 Global Anticoagulants Drug Consumption Value by Application (2018-2029)
    6.3 Global Anticoagulants Drug Average Price by Application (2018-2029)

7 North America
    7.1 North America Anticoagulants Drug Sales Quantity by Type (2018-2029)
    7.2 North America Anticoagulants Drug Sales Quantity by Application (2018-2029)
    7.3 North America Anticoagulants Drug Market Size by Country
        7.3.1 North America Anticoagulants Drug Sales Quantity by Country (2018-2029)
        7.3.2 North America Anticoagulants Drug Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Anticoagulants Drug Sales Quantity by Type (2018-2029)
    8.2 Europe Anticoagulants Drug Sales Quantity by Application (2018-2029)
    8.3 Europe Anticoagulants Drug Market Size by Country
        8.3.1 Europe Anticoagulants Drug Sales Quantity by Country (2018-2029)
        8.3.2 Europe Anticoagulants Drug Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Anticoagulants Drug Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Anticoagulants Drug Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Anticoagulants Drug Market Size by Region
        9.3.1 Asia-Pacific Anticoagulants Drug Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Anticoagulants Drug Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Anticoagulants Drug Sales Quantity by Type (2018-2029)
    10.2 South America Anticoagulants Drug Sales Quantity by Application (2018-2029)
    10.3 South America Anticoagulants Drug Market Size by Country
        10.3.1 South America Anticoagulants Drug Sales Quantity by Country (2018-2029)
        10.3.2 South America Anticoagulants Drug Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Anticoagulants Drug Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Anticoagulants Drug Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Anticoagulants Drug Market Size by Country
        11.3.1 Middle East & Africa Anticoagulants Drug Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Anticoagulants Drug Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Anticoagulants Drug Market Drivers
    12.2 Anticoagulants Drug Market Restraints
    12.3 Anticoagulants Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Anticoagulants Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Anticoagulants Drug
    13.3 Anticoagulants Drug Production Process
    13.4 Anticoagulants Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Anticoagulants Drug Typical Distributors
    14.3 Anticoagulants Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Anticoagulants Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Anticoagulants Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. C. H. Boehringer Sohn (Germany) Basic Information, Manufacturing Base and Competitors
    Table 4. C. H. Boehringer Sohn (Germany) Major Business
    Table 5. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Product and Services
    Table 6. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. C. H. Boehringer Sohn (Germany) Recent Developments/Updates
    Table 8. Bristol-Myers Squibb (US) Basic Information, Manufacturing Base and Competitors
    Table 9. Bristol-Myers Squibb (US) Major Business
    Table 10. Bristol-Myers Squibb (US) Anticoagulants Drug Product and Services
    Table 11. Bristol-Myers Squibb (US) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Bristol-Myers Squibb (US) Recent Developments/Updates
    Table 13. Johnson & Johnson (US) Basic Information, Manufacturing Base and Competitors
    Table 14. Johnson & Johnson (US) Major Business
    Table 15. Johnson & Johnson (US) Anticoagulants Drug Product and Services
    Table 16. Johnson & Johnson (US) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Johnson & Johnson (US) Recent Developments/Updates
    Table 18. Pfizer (US) Basic Information, Manufacturing Base and Competitors
    Table 19. Pfizer (US) Major Business
    Table 20. Pfizer (US) Anticoagulants Drug Product and Services
    Table 21. Pfizer (US) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Pfizer (US) Recent Developments/Updates
    Table 23. Daiichi Sankyo (Japan) Basic Information, Manufacturing Base and Competitors
    Table 24. Daiichi Sankyo (Japan) Major Business
    Table 25. Daiichi Sankyo (Japan) Anticoagulants Drug Product and Services
    Table 26. Daiichi Sankyo (Japan) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Daiichi Sankyo (Japan) Recent Developments/Updates
    Table 28. Portola Pharmaceuticals (US) Basic Information, Manufacturing Base and Competitors
    Table 29. Portola Pharmaceuticals (US) Major Business
    Table 30. Portola Pharmaceuticals (US) Anticoagulants Drug Product and Services
    Table 31. Portola Pharmaceuticals (US) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Portola Pharmaceuticals (US) Recent Developments/Updates
    Table 33. Roche (Switzerland) Basic Information, Manufacturing Base and Competitors
    Table 34. Roche (Switzerland) Major Business
    Table 35. Roche (Switzerland) Anticoagulants Drug Product and Services
    Table 36. Roche (Switzerland) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Roche (Switzerland) Recent Developments/Updates
    Table 38. Abbott (US) Basic Information, Manufacturing Base and Competitors
    Table 39. Abbott (US) Major Business
    Table 40. Abbott (US) Anticoagulants Drug Product and Services
    Table 41. Abbott (US) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Abbott (US) Recent Developments/Updates
    Table 43. Siemens (Germany) Basic Information, Manufacturing Base and Competitors
    Table 44. Siemens (Germany) Major Business
    Table 45. Siemens (Germany) Anticoagulants Drug Product and Services
    Table 46. Siemens (Germany) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Siemens (Germany) Recent Developments/Updates
    Table 48. Alere (US) Basic Information, Manufacturing Base and Competitors
    Table 49. Alere (US) Major Business
    Table 50. Alere (US) Anticoagulants Drug Product and Services
    Table 51. Alere (US) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Alere (US) Recent Developments/Updates
    Table 53. CoaguSense (US) Basic Information, Manufacturing Base and Competitors
    Table 54. CoaguSense (US) Major Business
    Table 55. CoaguSense (US) Anticoagulants Drug Product and Services
    Table 56. CoaguSense (US) Anticoagulants Drug Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. CoaguSense (US) Recent Developments/Updates
    Table 58. Global Anticoagulants Drug Sales Quantity by Manufacturer (2018-2023) & (K Pcs)
    Table 59. Global Anticoagulants Drug Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 60. Global Anticoagulants Drug Average Price by Manufacturer (2018-2023) & (USD/Pcs)
    Table 61. Market Position of Manufacturers in Anticoagulants Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 62. Head Office and Anticoagulants Drug Production Site of Key Manufacturer
    Table 63. Anticoagulants Drug Market: Company Product Type Footprint
    Table 64. Anticoagulants Drug Market: Company Product Application Footprint
    Table 65. Anticoagulants Drug New Market Entrants and Barriers to Market Entry
    Table 66. Anticoagulants Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 67. Global Anticoagulants Drug Sales Quantity by Region (2018-2023) & (K Pcs)
    Table 68. Global Anticoagulants Drug Sales Quantity by Region (2024-2029) & (K Pcs)
    Table 69. Global Anticoagulants Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 70. Global Anticoagulants Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 71. Global Anticoagulants Drug Average Price by Region (2018-2023) & (USD/Pcs)
    Table 72. Global Anticoagulants Drug Average Price by Region (2024-2029) & (USD/Pcs)
    Table 73. Global Anticoagulants Drug Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 74. Global Anticoagulants Drug Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 75. Global Anticoagulants Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Global Anticoagulants Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Global Anticoagulants Drug Average Price by Type (2018-2023) & (USD/Pcs)
    Table 78. Global Anticoagulants Drug Average Price by Type (2024-2029) & (USD/Pcs)
    Table 79. Global Anticoagulants Drug Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 80. Global Anticoagulants Drug Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 81. Global Anticoagulants Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 82. Global Anticoagulants Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 83. Global Anticoagulants Drug Average Price by Application (2018-2023) & (USD/Pcs)
    Table 84. Global Anticoagulants Drug Average Price by Application (2024-2029) & (USD/Pcs)
    Table 85. North America Anticoagulants Drug Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 86. North America Anticoagulants Drug Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 87. North America Anticoagulants Drug Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 88. North America Anticoagulants Drug Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 89. North America Anticoagulants Drug Sales Quantity by Country (2018-2023) & (K Pcs)
    Table 90. North America Anticoagulants Drug Sales Quantity by Country (2024-2029) & (K Pcs)
    Table 91. North America Anticoagulants Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. North America Anticoagulants Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Europe Anticoagulants Drug Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 94. Europe Anticoagulants Drug Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 95. Europe Anticoagulants Drug Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 96. Europe Anticoagulants Drug Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 97. Europe Anticoagulants Drug Sales Quantity by Country (2018-2023) & (K Pcs)
    Table 98. Europe Anticoagulants Drug Sales Quantity by Country (2024-2029) & (K Pcs)
    Table 99. Europe Anticoagulants Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 100. Europe Anticoagulants Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 101. Asia-Pacific Anticoagulants Drug Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 102. Asia-Pacific Anticoagulants Drug Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 103. Asia-Pacific Anticoagulants Drug Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 104. Asia-Pacific Anticoagulants Drug Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 105. Asia-Pacific Anticoagulants Drug Sales Quantity by Region (2018-2023) & (K Pcs)
    Table 106. Asia-Pacific Anticoagulants Drug Sales Quantity by Region (2024-2029) & (K Pcs)
    Table 107. Asia-Pacific Anticoagulants Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 108. Asia-Pacific Anticoagulants Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 109. South America Anticoagulants Drug Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 110. South America Anticoagulants Drug Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 111. South America Anticoagulants Drug Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 112. South America Anticoagulants Drug Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 113. South America Anticoagulants Drug Sales Quantity by Country (2018-2023) & (K Pcs)
    Table 114. South America Anticoagulants Drug Sales Quantity by Country (2024-2029) & (K Pcs)
    Table 115. South America Anticoagulants Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 116. South America Anticoagulants Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 117. Middle East & Africa Anticoagulants Drug Sales Quantity by Type (2018-2023) & (K Pcs)
    Table 118. Middle East & Africa Anticoagulants Drug Sales Quantity by Type (2024-2029) & (K Pcs)
    Table 119. Middle East & Africa Anticoagulants Drug Sales Quantity by Application (2018-2023) & (K Pcs)
    Table 120. Middle East & Africa Anticoagulants Drug Sales Quantity by Application (2024-2029) & (K Pcs)
    Table 121. Middle East & Africa Anticoagulants Drug Sales Quantity by Region (2018-2023) & (K Pcs)
    Table 122. Middle East & Africa Anticoagulants Drug Sales Quantity by Region (2024-2029) & (K Pcs)
    Table 123. Middle East & Africa Anticoagulants Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Anticoagulants Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 125. Anticoagulants Drug Raw Material
    Table 126. Key Manufacturers of Anticoagulants Drug Raw Materials
    Table 127. Anticoagulants Drug Typical Distributors
    Table 128. Anticoagulants Drug Typical Customers
List of Figures
    Figure 1. Anticoagulants Drug Picture
    Figure 2. Global Anticoagulants Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Anticoagulants Drug Consumption Value Market Share by Type in 2022
    Figure 4. Novel Oral Anticoagulants (NOACs) Examples
    Figure 5. Warfarin (VKA) Examples
    Figure 6. Others Examples
    Figure 7. Global Anticoagulants Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Anticoagulants Drug Consumption Value Market Share by Application in 2022
    Figure 9. Hospital Examples
    Figure 10. Clinic Examples
    Figure 11. Others Examples
    Figure 12. Global Anticoagulants Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Anticoagulants Drug Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Anticoagulants Drug Sales Quantity (2018-2029) & (K Pcs)
    Figure 15. Global Anticoagulants Drug Average Price (2018-2029) & (USD/Pcs)
    Figure 16. Global Anticoagulants Drug Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Anticoagulants Drug Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Anticoagulants Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Anticoagulants Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Anticoagulants Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Anticoagulants Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Anticoagulants Drug Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Anticoagulants Drug Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Anticoagulants Drug Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Anticoagulants Drug Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Anticoagulants Drug Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Anticoagulants Drug Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Anticoagulants Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Anticoagulants Drug Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Anticoagulants Drug Average Price by Type (2018-2029) & (USD/Pcs)
    Figure 31. Global Anticoagulants Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Anticoagulants Drug Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Anticoagulants Drug Average Price by Application (2018-2029) & (USD/Pcs)
    Figure 34. North America Anticoagulants Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Anticoagulants Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Anticoagulants Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Anticoagulants Drug Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Anticoagulants Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Anticoagulants Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Anticoagulants Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Anticoagulants Drug Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Anticoagulants Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Anticoagulants Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Anticoagulants Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Anticoagulants Drug Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Anticoagulants Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Anticoagulants Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Anticoagulants Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Anticoagulants Drug Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Anticoagulants Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Anticoagulants Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Anticoagulants Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Anticoagulants Drug Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Anticoagulants Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Anticoagulants Drug Market Drivers
    Figure 75. Anticoagulants Drug Market Restraints
    Figure 76. Anticoagulants Drug Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Anticoagulants Drug in 2022
    Figure 79. Manufacturing Process Analysis of Anticoagulants Drug
    Figure 80. Anticoagulants Drug Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

C. H. Boehringer Sohn (Germany)
Bristol-Myers Squibb (US)
Johnson & Johnson (US)
Pfizer (US)
Daiichi Sankyo (Japan)
Portola Pharmaceuticals (US)
Roche (Switzerland)
Abbott (US)
Siemens (Germany)
Alere (US)
CoaguSense (US)

Related Reports

Global Anticoagulants Drug Supply, Demand and Key Producers, 2023-2029

Global Anticoagulants Drug Supply, Demand and Key Producers, 2023-2029

date 13 Feb 2023

date Pharma & Healthcare

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.

Global Anticoagulants Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Anticoagulants Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 23 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Anticoagulants Drug market size was valued at USD 30180 million in 2023 and is forecast to a readjusted size of USD 37520 million by 2030 with a CAGR of 3.2% during review period.

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>